Outcomes of Vitreo-Retinal interventions in eyes treated for retinoblastoma.

Session Details

Session Title: Free Paper Session 15: Mixed Session

Session Date/Time: Friday 08/09/2017 | 16:30-18:00

Paper Time: 16:48

Venue: Room 117

First Author: : K.Bhatia INDIA

Co Author(s): :    R. Rao   S. Honavar   A. Majji                       

Abstract Details


To evaluate the safety and outcomes of Vitreo-retinal interventions in eyes treated for retinoblastoma.


A retrospective, non-comparative, interventional case series conducted at tertiary eye hospital in India.


14 eyes having Vitreo-retinal problems, which had completed treatment for retinoblastoma, underwent either 3-port pars plana vitrectomy and/or non-drainage scleral buckling. Cytology of the cassette fluid for the presence of malignant cells was done in all the patients undergoing vitrectomy.


10 eyes underwent pars plana vitrectomy, 3 eyes underwent scleral buckling, and combined surgery was done in 1 eye. Major indications of surgery were retinal detachment (7 eyes), vitreous haemhorrage, and Epiretinal membrane. Mean age of patients was 27 months (6-60 months). Mean time of surgical intervention since complete tumour regression was 13 months (3-60 months). Mean follow up was 23 months (3-72 months). Anatomical success was achieved in all eyes (100%). One eye had vitreous haemhorrage as complication (7%), and 2 eyes (14%) had tumour recurrence. All 3 eyes were enucleated. 3 eyes (27%, N=11) had final visual acuity of 20/400-20/60. 6 eyes (55%, N=11) had visual acuity of 20/60-20/20. Salvage of life was achieved in all (N=14, 100%), eye salvage was achieved in 11 eyes (79%), and vision salvage was achieved in 8 eyes (72%).


Vitreo-Retinal interventions can have good anatomical and functional outcomes in patients who have completed retinoblastoma treatment. Surgery can be performed after 6 months of tumour regression. Chances of recurrence and metastasis are very low.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy